Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för G Leonard Jr Baker. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att G Leonard Jr Baker har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:CORT / Corcept Therapeutics Incorporated | Director | 3 308 303 |
US:MATR / Mattersight Corp. | 10% Owner | 85 838 |
US:THLD / Threshold Pharmaceuticals, Inc. | 10% Owner | 0 |
US:CRDC / Cardica, Inc. | 10% Owner | 3 412 793 |
US:QNST / QuinStreet, Inc. | 10% Owner | 54 547 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av G Leonard Jr Baker. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CORT / Corcept Therapeutics Incorporated - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp QNST / QuinStreet, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av G Leonard Jr Baker som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 308 303 | 0,00 | ||||
2024-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 308 303 | 0,00 | ||||
2023-07-18 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 308 303 | 0,00 | ||||
2023-02-14 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | −207 | 1 046 631 | −0,02 | ||||
2023-02-14 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 207 | 955 262 | 0,02 | ||||
2023-02-14 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 308 303 | 0,00 | ||||
2022-02-14 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 308 303 | 0,00 | ||||
2021-06-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 3 308 303 | 3,12 | 21,53 | 2 153 000 | 71 227 764 | |
2021-06-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 50 000 | 1 046 838 | 5,02 | 21,53 | 1 076 500 | 22 538 422 | |
2021-05-28 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 20 000 | 20 000 | |||||
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 146 838 | 2,69 | 1,74 | 52 200 | 1 995 498 | |
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 146 838 | 2,69 | 1,74 | 52 200 | 1 995 498 | |
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 086 838 | 2,84 | 4,05 | 121 500 | 4 401 694 | |
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 056 838 | 2,92 | 4,42 | 132 600 | 4 671 224 | |
2021-05-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 026 838 | 3,01 | 6,55 | 196 500 | 6 725 789 | |
2021-02-03 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 114 793 | 0,00 | ||||
2020-12-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 68 | 3 208 303 | 0,00 | 22,64 | 1 540 | 72 635 980 | |
2020-12-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 1 109 | 3 208 235 | 0,03 | 22,80 | 25 285 | 73 147 758 | |
2020-11-30 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 361 | 3 207 126 | 0,01 | 22,81 | 8 233 | 73 140 112 | |
2020-11-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 1 429 | 3 206 765 | 0,04 | 22,93 | 32 766 | 73 528 556 | |
2020-11-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 1 551 | 3 205 336 | 0,05 | 22,93 | 35 562 | 73 493 226 | |
2020-11-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 2 372 | 3 203 785 | 0,07 | 17,91 | 42 491 | 57 390 682 | |
2020-11-17 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 7 883 | 3 201 413 | 0,25 | 17,82 | 140 469 | 57 046 619 | |
2020-11-17 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 200 | 3 193 530 | 0,01 | 17,94 | 3 588 | 57 291 928 | |
2020-11-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 15 000 | 3 193 330 | 0,47 | 17,71 | 265 635 | 56 550 681 | |
2020-11-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 3 786 | 3 178 330 | 0,12 | 17,96 | 68 013 | 57 096 791 | |
2020-11-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 13 500 | 3 174 544 | 0,43 | 17,98 | 242 665 | 57 063 063 | |
2020-09-01 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 25 807 | 3 161 044 | 0,82 | 12,50 | 322 526 | 39 505 463 | |
2020-09-01 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 20 444 | 3 135 237 | 0,66 | 12,48 | 255 213 | 39 138 731 | |
2020-05-29 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2020-05-29 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −30 000 | 996 838 | −2,92 | 15,70 | −471 060 | 15 652 350 | |
2020-05-29 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 026 838 | 3,01 | 3,47 | 104 100 | 3 563 128 | |
2020-05-29 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2020-03-05 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 044 793 | 0,00 | ||||
2019-06-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 25 000 | 25 000 | |||||
2019-06-05 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2019-06-05 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −30 000 | 996 838 | −2,92 | 9,78 | −293 298 | 9 745 686 | |
2019-06-05 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 1 026 838 | 3,01 | 0,96 | 28 800 | 985 764 | |
2019-02-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 70 000 | 3 114 793 | 2,30 | 11,39 | 797 097 | 35 468 459 | |
2019-02-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 30 000 | 996 838 | 3,10 | 11,39 | 341 613 | 11 351 094 | |
2019-02-11 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 3 044 793 | 0,00 | ||||
2018-11-26 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 70 000 | 3 044 793 | 2,35 | 12,73 | 890 785 | 38 746 513 | |
2018-11-26 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 30 000 | 966 838 | 3,20 | 12,73 | 381 765 | 12 303 497 | |
2018-11-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 25 420 | 2 974 793 | 0,86 | 12,87 | 327 105 | 38 279 636 | |
2018-11-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 10 895 | 936 838 | 1,18 | 12,87 | 140 197 | 12 055 231 | |
2018-11-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 73 914 | 2 949 373 | 2,57 | 12,94 | 956 698 | 38 174 914 | |
2018-11-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 31 677 | 925 943 | 3,54 | 12,94 | 410 008 | 11 984 851 | |
2018-11-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 40 666 | 2 875 459 | 1,43 | 13,00 | 528 658 | 37 380 967 | |
2018-11-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 17 428 | 894 266 | 1,99 | 13,00 | 226 564 | 11 625 458 | |
2018-08-22 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 25 000 | 25 000 | |||||
2018-08-22 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 35 681 | 2 834 793 | 1,27 | 12,92 | 461 095 | 36 633 180 | |
2018-08-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 5 792 | 2 799 112 | 0,21 | 12,80 | 74 117 | 35 818 837 | |
2018-08-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 2 793 320 | 3,71 | 12,49 | 1 248 760 | 34 881 863 | |
2018-08-16 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 79 686 | 2 693 320 | 3,05 | 12,49 | 994 967 | 33 629 063 | |
2018-08-16 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 876 838 | 12,87 | 12,47 | 1 247 000 | 10 934 170 | |
2018-05-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2018-05-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −30 000 | 776 838 | −3,72 | 16,01 | −480 312 | 12 437 487 | |
2018-05-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 806 838 | 3,86 | 2,23 | 66 900 | 1 799 249 | |
2018-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 2 613 634 | 0,00 | ||||
2017-11-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
M - Exercise | −30 000 | 0 | −100,00 | ||||
2017-11-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −30 000 | 776 838 | −3,72 | 17,59 | −527 556 | 13 660 852 | |
2017-11-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
M - Exercise | 30 000 | 806 838 | 3,86 | 2,70 | 81 000 | 2 178 463 | |
2017-05-26 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2017-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 2 613 634 | 0,00 | ||||
2017-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 0 | 2 613 634 | 0,00 | ||||
2016-07-25 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2016-05-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 29 498 | 776 838 | 3,95 | 5,00 | 147 629 | 3 887 841 | |
2016-05-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 26 302 | 747 340 | 3,65 | 4,88 | 128 380 | 3 647 767 | |
2016-05-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 44 200 | 721 038 | 6,53 | 4,79 | 211 886 | 3 456 512 | |
2016-02-12 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 2 613 634 | 0,00 | ||||
2016-02-12 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 2 613 634 | 0,00 | ||||
2016-02-12 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 2 613 634 | 0,00 | ||||
2015-09-30 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 46 | 955 055 | 0,00 | ||||
2015-09-30 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −280 365 | 0 | −100,00 | ||||
2015-09-30 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 27 595 | 2 613 634 | 1,07 | ||||
2015-08-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 900 | 955 009 | 0,09 | ||||
2015-08-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −5 509 043 | 280 365 | −95,16 | ||||
2015-08-14 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 542 210 | 2 586 039 | 26,53 | ||||
2015-06-22 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −1 596 | 0 | −100,00 | 0,12 | −200 | ||
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −280 365 | 0 | −100,00 | 0,12 | −35 046 | ||
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −46 791 | 0 | −100,00 | 0,12 | −5 849 | ||
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −98 449 | 0 | −100,00 | 0,12 | −12 306 | ||
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 1 596 | 954 109 | 0,17 | 4,05 | 6 464 | 3 864 141 | |
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 280 365 | 5 789 408 | 5,09 | 4,05 | 1 135 478 | 23 447 102 | |
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 46 791 | 2 043 829 | 2,34 | 4,05 | 189 504 | 8 277 507 | |
2015-03-31 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 98 449 | 98 449 | 4,05 | 398 718 | 398 718 | ||
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −230 841 | 0 | −100,00 | 2,77 | −639 430 | ||
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −364 821 | 0 | −100,00 | 2,77 | −1 010 554 | ||
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −68 224 | 0 | −100,00 | 2,77 | −188 980 | ||
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −109 306 | 952 513 | −10,29 | 5,85 | −639 440 | 5 572 201 | |
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 230 841 | 1 061 819 | 27,78 | 2,77 | 639 430 | 2 941 239 | |
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −172 745 | 5 509 043 | −3,04 | 5,85 | −1 010 558 | 32 227 902 | |
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 364 821 | 5 681 788 | 6,86 | 2,77 | 1 010 554 | 15 738 553 | |
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
S - Sale | −32 305 | 1 997 038 | −1,59 | 5,85 | −188 984 | 11 682 672 | |
2015-03-24 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 68 224 | 2 029 343 | 3,48 | 2,77 | 188 980 | 5 621 280 | |
2015-02-09 |
|
5 | MATR |
Mattersight Corp
Common Stock |
J - Other | 0 | 85 838 | 0,00 | ||||
2015-02-09 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 1 961 119 | 0,00 | ||||
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −11 623 | 0 | −100,00 | ||||
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −417 050 | 0 | −100,00 | ||||
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −6 977 | 0 | −100,00 | ||||
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 316 | 132 161 | −4,56 | 3,77 | −23 824 | 498 511 | |
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 11 623 | 138 477 | 9,16 | 2,05 | 23 827 | 283 878 | |
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −226 657 | 4 715 398 | −4,59 | 3,77 | −854 950 | 17 786 481 | |
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 417 050 | 4 942 055 | 9,22 | 2,05 | 854 952 | 10 131 213 | |
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 791 | 74 610 | −4,84 | 3,77 | −14 300 | 281 429 | |
2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 6 977 | 78 401 | 9,77 | 2,05 | 14 303 | 160 722 | |
2014-06-23 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 028 | 0 | −100,00 | 4,01 | −40 193 | ||
2014-06-23 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 960 | 0 | −100,00 | 4,01 | −15 872 | ||
2014-06-16 |
|
4 | MATR |
Mattersight Corp
Series B Preferred Stock |
S - Sale | −22 418 | 0 | −100,00 | 5,82 | −130 473 | ||
2014-06-16 |
|
4 | MATR |
Mattersight Corp
Series B Preferred Stock |
S - Sale | −8 854 | 0 | −100,00 | 5,82 | −51 530 | ||
2014-06-16 |
|
4 | MATR |
Mattersight Corp
Common Stock |
S - Sale | −14 847 | 0 | −100,00 | 5,12 | −76 017 | ||
2014-06-16 |
|
4 | MATR |
Mattersight Corp
Common Stock |
S - Sale | −5 853 | 0 | −100,00 | 5,12 | −29 967 | ||
2014-06-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 29 273 | 830 978 | 3,65 | 2,32 | 67 913 | 1 927 869 | |
2014-06-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 74 113 | 801 705 | 10,19 | 2,32 | 171 942 | 1 859 956 | |
2014-05-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 578 389 | 20,90 | 1,84 | 184 290 | 1 065 913 | |
2014-05-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2014-02-13 |
|
5 | MATR |
Mattersight Corp
Common Stock |
J - Other | 0 | 85 838 | 0,00 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 1 961 119 | 0,00 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 4 900 | 1 961 119 | 0,25 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 15 200 | 1 956 219 | 0,78 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 20 100 | 1 941 019 | 1,05 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 46 931 | 1 920 919 | 2,50 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −20 100 | 0 | −100,00 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −46 931 | 0 | −100,00 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −4 900 | 0 | −100,00 | ||||
2014-02-13 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −15 200 | 0 | −100,00 | ||||
2014-02-13 |
|
5 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
J - Other | 0 | 71 424 | 0,00 | ||||
2013-12-05 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 18 728 | 103 860 | 22,00 | 3,90 | 73 039 | 405 054 | |
2013-12-05 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 225 846 | 2 443 889 | 10,18 | 3,90 | 880 799 | 9 531 167 | |
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −18 939 | 0 | −100,00 | ||||
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −801 952 | 0 | −100,00 | ||||
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −10 844 | 0 | −100,00 | ||||
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 153 | 126 854 | −4,63 | 5,72 | −35 220 | 726 112 | |
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 18 939 | 133 007 | 16,60 | 1,86 | 35 227 | 247 393 | |
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −260 592 | 4 525 005 | −5,45 | 5,72 | −1 491 629 | 25 901 129 | |
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 801 952 | 4 785 597 | 20,13 | 1,86 | 1 491 631 | 8 901 210 | |
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 523 | 71 424 | −4,70 | 5,72 | −20 166 | 408 831 | |
2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 10 844 | 74 947 | 16,92 | 1,86 | 20 170 | 139 401 | |
2013-05-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 981 736 | 3 412 793 | 40,38 | 1,05 | 1 030 823 | 3 583 433 | |
2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 43 135 | 154 412 | 38,76 | 1,05 | 45 292 | 162 133 | |
2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 52 899 | 189 364 | 38,76 | 1,05 | 55 544 | 198 832 | |
2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 981 736 | 3 412 793 | 40,38 | 1,05 | 1 030 823 | 3 583 433 | |
2013-01-25 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 1 873 988 | 0,00 | ||||
2013-01-25 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | −482 906 | 727 592 | −39,89 | ||||
2013-01-25 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 205 232 | 1 573 988 | 14,99 | ||||
2013-01-25 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | 482 906 | 1 368 756 | 54,51 | ||||
2013-01-25 |
|
5 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
G - Gift | −205 232 | 478 389 | −30,02 | ||||
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 5 600 | 20 100 | 38,62 | 1,50 | 8 397 | 30 138 | |
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 12 931 | 46 931 | 38,03 | 1,50 | 19 389 | 70 368 | |
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 1 400 | 4 900 | 40,00 | 1,50 | 2 099 | 7 347 | |
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 4 200 | 15 200 | 38,18 | 1,50 | 6 297 | 22 791 | |
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 14 500 | 14 500 | 1,45 | 20 980 | 20 980 | ||
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 34 000 | 34 000 | 1,45 | 49 195 | 49 195 | ||
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 3 500 | 3 500 | 1,45 | 5 064 | 5 064 | ||
2012-12-06 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 11 000 | 11 000 | 1,45 | 15 916 | 15 916 | ||
2012-11-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 0 | 1 185 850 | 0,00 | ||||
2012-11-07 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 1 185 850 | 9,21 | 1,60 | 159 790 | 1 894 870 | |
2012-11-07 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 1 085 850 | 10,14 | 1,93 | 192 840 | 2 093 953 | |
2012-11-07 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 985 850 | 11,29 | 1,97 | 197 230 | 1 944 392 | |
2012-09-06 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 185 962 | 2 218 043 | 9,15 | 5,40 | 1 004 846 | 11 985 195 | |
2012-09-06 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 185 962 | 2 218 043 | 9,15 | 5,40 | 1 004 846 | 11 985 195 | |
2012-09-06 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 6 618 | 7 981 | 485,55 | 5,40 | 35 760 | 43 125 | |
2012-08-31 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 18 640 | 2 032 081 | 0,93 | 5,31 | 98 949 | 10 787 099 | |
2012-08-31 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 18 640 | 2 032 081 | 0,93 | 5,31 | 98 949 | 10 787 099 | |
2012-08-31 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 663 | 1 363 | 94,71 | 5,31 | 3 519 | 7 235 | |
2012-08-23 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 19 682 | 2 013 441 | 0,99 | 5,00 | 98 410 | 10 067 205 | |
2012-08-23 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 700 | 700 | 5,00 | 3 500 | 3 500 | ||
2012-08-21 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 3 500 | 1 993 759 | 0,18 | 4,81 | 16 837 | 9 591 376 | |
2012-08-21 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 3 500 | 1 993 759 | 0,18 | 4,81 | 16 837 | 9 591 376 | |
2012-06-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −280 365 | 0 | −100,00 | 0,12 | −35 046 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 280 365 | 280 365 | 0,12 | 35 046 | 35 046 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 280 365 | 5 316 967 | 5,57 | 2,96 | 829 880 | 15 738 222 | |
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −1 596 | 0 | −100,00 | 0,12 | −200 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 1 596 | 1 596 | 0,12 | 200 | 200 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −46 791 | 0 | −100,00 | 0,12 | −5 849 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 46 791 | 46 791 | 0,12 | 5 849 | 5 849 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −98 449 | 0 | −100,00 | 0,12 | −12 306 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 98 449 | 98 449 | 0,12 | 12 306 | 12 306 | ||
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 1 596 | 1 210 498 | 0,13 | 2,96 | 4 724 | 3 583 074 | |
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 46 791 | 885 850 | 5,58 | 2,96 | 138 501 | 2 622 116 | |
2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 98 449 | 478 182 | 25,93 | 2,96 | 291 409 | 1 415 419 | |
2012-02-14 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 322 857 | 2 431 057 | 15,31 | 1,65 | 532 714 | 4 011 244 | |
2012-02-14 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 14 572 | 111 277 | 15,07 | 1,65 | 24 044 | 183 607 | |
2012-02-14 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 17 871 | 136 465 | 15,07 | 1,65 | 29 487 | 225 167 | |
2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
54 547 | ||||||||
2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
1 628 | ||||||||
2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
643 | ||||||||
2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
3 582 | ||||||||
2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
2 079 | ||||||||
2009-06-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 61 069 | 228 765 | 36,42 | 0,12 | 7 634 | 28 596 | |
2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 53 640 | 400 199 | 15,48 | 0,12 | 6 705 | 50 025 | |
2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 15 267 | 68 224 | 28,83 | 0,12 | 1 908 | 8 528 | |
2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 571 426 | 1 180 231 | 93,86 | 0,69 | 392 570 | 810 819 | |
2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 501 910 | 4 338 742 | 13,08 | 0,69 | 344 812 | 2 980 716 | |
2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 142 860 | 658 580 | 27,70 | 0,69 | 98 145 | 452 444 | |
2008-11-21 | 3/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
36 122 | ||||||||
2008-11-21 | 3/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
3 960 | ||||||||
2008-11-21 | 3/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
10 028 | ||||||||
2008-11-21 | 3/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
2 535 249 | ||||||||
2008-11-21 | 3/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
54 298 | ||||||||
2008-11-13 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 33 195 | 608 805 | 5,77 | ||||
2008-11-13 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 68 601 | 3 836 832 | 1,82 | ||||
2008-11-13 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 10 482 | 515 720 | 2,07 | ||||
2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
3 840 | ||||||||
2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
36 122 | ||||||||
2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
3 960 | ||||||||
2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
10 028 | ||||||||
2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
2 535 249 | ||||||||
2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
50 458 | ||||||||
2008-06-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 167 696 | 167 696 | 0,12 | 20 962 | 20 962 | ||
2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 346 559 | 346 559 | 0,12 | 43 320 | 43 320 | ||
2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 52 957 | 52 957 | 0,12 | 6 620 | 6 620 | ||
2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 335 393 | 575 610 | 139,62 | 2,77 | 929 039 | 1 594 440 | |
2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 693 118 | 3 768 231 | 22,54 | 2,77 | 1 919 937 | 10 438 000 | |
2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 105 914 | 505 238 | 26,52 | 2,77 | 293 382 | 1 399 509 | |
2007-12-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Stock Option (Right To Buy) |
A - Award | 30 000 | 30 000 | |||||
2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
111 | ||||||||
2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
22 | ||||||||
2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
56 | ||||||||
2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
211 736 | ||||||||
2007-09-25 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 42 784 | 240 217 | 21,67 | ||||
2007-09-25 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −468 492 | 3 075 113 | −13,22 | ||||
2007-08-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 95 238 | 197 433 | 93,19 | 2,10 | 200 000 | 414 609 | |
2007-08-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 162 218 | 3 543 605 | 4,80 | 2,10 | 340 658 | 7 441 570 | |
2007-08-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 47 619 | 399 324 | 13,54 | 2,10 | 100 000 | 838 580 | |
2006-12-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 12 621 | 30 199 | 71,80 | 1,00 | 12 621 | 30 199 | |
2006-12-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 379 391 | 2 590 040 | 17,16 | 1,00 | 379 391 | 2 590 040 | |
2006-12-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 12 621 | 269 395 | 4,92 | 1,00 | 12 621 | 269 395 | |
2005-12-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −5 539 | 2 210 649 | −0,25 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −966 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −121 780 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −3 109 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −1 228 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −12 392 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −3 369 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −1 507 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −5 812 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −732 882 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −18 736 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −7 400 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −56 516 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −201 863 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −189 980 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −4 873 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −1 925 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −25 774 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −2 093 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −263 862 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −6 768 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −2 673 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −36 848 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −69 | 0 | −100,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 5 812 | 17 578 | 49,40 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 966 | 11 766 | 8,94 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 4 521 | 10 800 | 72,00 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 6 279 | 6 279 | |||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 732 882 | 2 216 188 | 49,41 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 569 940 | 1 483 306 | 62,40 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 121 780 | 913 366 | 15,38 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 791 586 | 791 586 | |||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 18 736 | 56 768 | 49,26 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 14 619 | 38 032 | 62,44 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 3 109 | 23 413 | 15,31 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 20 304 | 20 304 | |||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 7 400 | 22 422 | 49,26 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 5 775 | 15 022 | 62,45 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 1 228 | 9 247 | 15,31 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 8 019 | 8 019 | |||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 56 516 | 256 774 | 28,22 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 12 392 | 200 258 | 6,60 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 77 322 | 187 866 | 69,95 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 110 544 | 110 544 | |||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 201 863 | 205 439 | 5 644,94 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 3 369 | 3 576 | 1 627,54 | ||||
2004-04-20 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 207 | 207 | |||||
2004-04-14 | 3 | CORT |
CORCEPT THERAPEUTICS INC
No securities |
0 |